News about Drug Discovery & Development

VoxCell BioInnovation Partners with AdMare BioInnovations to Advance Human-Relevant Cancer Drug Testing

VoxCell BioInnovation and adMare BioInnovations have launched a research partnership focused on validating antibody-based cancer therapies using advanced bioprinted human tissue models designed to improve predictive drug testing and accelerate oncology innovation.

Drug Discovery & Development | 15/05/2026 | By News Bureau |  137

Fosun Pharma and AriBio Sign Global Deal for AR1001 to Treat Alzheimer's

Fosun Pharma and AriBio signed an exclusive global option agreement for AR1001, an investigational Alzheimer’s disease treatment, with a USD 60 million option fee.

Drug Discovery & Development | 14/05/2026 | By News Bureau |  266

The University of Tulsa Researchers Develop Potential Brain Cancer Compounds With Enhanced Targeting Ability

Scientists at The University of Tulsa have developed new memantine-based compounds capable of crossing the blood-brain barrier and demonstrating higher anticancer activity against glioblastoma cells than standard chemotherapy treatments.

Drug Discovery & Development | 12/05/2026 | By News Bureau |  123

Formosa Pharmaceuticals Partners with Singapore Eye Research Institute for Corneal Disease Therapies

Formosa Pharmaceuticals partners with Singapore Eye Research Institute to develop next-generation ophthalmic formulations using APNT nanoparticle technology and advanced clinical research expertise for corneal diseases.

Drug Discovery & Development | 02/05/2026 | By News Bureau |  138

Nagaland University Converts Invasive Plant into Breakthrough for Drugs, Antibacterial and Cancer Research

A research team from Nagaland University has developed an eco-friendly method to convert the invasive plant Mikania micrantha into silver nanoparticles, boosting drug production, antibacterial activity, and promising cancer research without toxic chemicals.

Drug Discovery & Development | 22/04/2026 | By News Bureau |  127

Partner Therapeutics Submits sBLA to FDA for BIZENGRI

Partner Therapeutics submits sBLA to FDA for BIZENGRI in NRG1 fusion-positive cholangiocarcinoma, supported by eNRGy study data showing 36.8 percent response rate and durable efficacy.

Drug Discovery & Development | 15/04/2026 | By News Bureau |  150

Haisco Signs Exclusive Deal with AbbVie to Develop Novel Pain Therapies

Haisco partners with AbbVie to develop novel pain therapies, with multiple compounds in preclinical to Phase 1 stages targeting pain-related conditions.

Drug Discovery & Development | 13/04/2026 | By News Bureau |  160

Artivion Secures US FDA Approval for Endospan's NEXUS Aortic Arch System

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that the US Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the NEXUS Aortic Arch System, developed by Endospan Ltd. (Endospan), Artivion's long-standing partner.

Drug Discovery & Development | 08/04/2026 | By Darshana |  152

Concept Medical Unveils Landmark SirPAD Trial at ACC 2026, Advancing PAD Treatment

Concept Medical Inc. (CMI), a global leader in drug-delivery technologies for vascular interventions, has announced the presentation of the world’s largest randomized controlled trial evaluating a sirolimus-coated balloon (SCB) for peripheral artery disease (PAD) at the ACC 2026 Scientific Sessions.

Drug Discovery & Development | 01/04/2026 | By Darshana |  205

Wockhardt's Zaynich Gets CDSCO SEC Nod for Gram-Negative Infections

CDSCO’s Subject Expert Committee (SEC) recommends Wockhardt’s Zaynich (Zidebactam/Cefepime) for Gram-negative infections, paving the way for DCGI approval of the novel antibiotic in India.

Drug Discovery & Development | 30/03/2026 | By News Bureau |  330